肿瘤(癌症)患者之家
首页
癌症知识
肿瘤中医药治疗
肿瘤药膳
肿瘤治疗技术
前沿资讯
登录/注册
VIP特权

文章目录

microRNA-9-5p通过抑制PDK4调控肝癌细胞线粒体功能

microRNA-9-5p regulates the mitochondrial function of hepatocellular carcinoma cells through suppressing PDK4 

原文发布日期:2020-11-30 

英文摘要:

摘要翻译: 

原文链接:

文章:

microRNA-9-5p通过抑制PDK4调控肝癌细胞线粒体功能

microRNA-9-5p regulates the mitochondrial function of hepatocellular carcinoma cells through suppressing PDK4 

原文发布日期:2020-11-30 

英文摘要:

Due to the lack of early diagnostic and effective treatment modalities, hepatocellular carcinoma (HCC) is still the most lethal cancer with a high mortality on a global scale. Recent studies have highlighted the key roles of microRNAs (miRs) in HCC development. In the study, we attempted to investigate the potential role of miR-9-5p in the progression of HCC. Expression of pyruvate dehydrogenase kinase 4 (PDK4) and miR-9-5p was examined in HCC tissues collected from HCC patients and cell lines. The proliferation, migration, invasion, and apoptosis of HCC cells, and levels of oxygen consumption rate, extracellular acidification rate and reactive oxygen species (ROS) as well as the tumorigenicity of transfected cells in vivo were measured after gain- and loss-of-function experiments in HCC cells. It was revealed that miR-9-5p was upregulated, while PDK4 was poorly expressed in HCC tissues and cells, associating with a poor prognosis of HCC patients. miR-9-5p directly targeted PDK4 and could downregulate its expression, thus leading to promoted cell proliferation, invasion and migration, enhanced mitochondrial activity and energy metabolism, and suppressed apoptosis in HCC cells, along with increased tumorigenicity in mouse xenograft models. Altogether, miR-9-5p facilitated mitochondrial energy metabolism of HCC cells by downregulating PDK4, promoting the development of HCC. miR-9-5p and PDK4 may serve as potential therapeutic targets for preventing recurrence and metastasis of HCC. 

摘要翻译: 

由于缺乏早期诊断和有效治疗手段,肝细胞癌(HCC)仍是全球范围内死亡率最高的致命癌症。近期研究揭示了微小RNA(miR)在HCC发展中的关键作用。本研究旨在探讨miR-9-5p在HCC进展中的潜在作用。我们检测了HCC患者癌组织及细胞系中丙酮酸脱氢酶激酶4(PDK4)和miR-9-5p的表达水平,并通过功能增益与缺失实验评估了HCC细胞的增殖、迁移、侵袭、凋亡能力、耗氧率、细胞外酸化率和活性氧(ROS)水平,以及转染细胞在体内的致瘤性。结果显示:miR-9-5p在HCC组织和细胞中表达上调,而PDK4呈低表达状态,且与HCC患者不良预后相关;miR-9-5p可直接靶向PDK4并下调其表达,从而促进HCC细胞增殖、侵袭和迁移,增强线粒体活性和能量代谢,抑制细胞凋亡,同时提高小鼠异种移植模型的致瘤性。综上,miR-9-5p通过下调PDK4促进HCC细胞线粒体能量代谢,进而推动HCC发展。miR-9-5p与PDK4可能成为预防HCC复发和转移的潜在治疗靶点。

原文链接:

microRNA-9-5p regulates the mitochondrial function of hepatocellular carcinoma cells through suppressing PDK4

相关文章

文章:肿瘤抗原优先来源于黑色素瘤和非小细胞肺癌中未突变的基因组序列
文章:年龄相关的烟酰胺腺嘌呤二核苷酸下降驱动CAR-T细胞衰竭
文章:MCSP+转移创始细胞在人类黑色素瘤转移定植早期激活免疫抑制
文章:脂质纳米颗粒递送合成抗原使实体瘤对car介导的细胞毒性敏感
文章:食管癌新辅助治疗中的进化和免疫微环境动力学
文章:CHD1缺失重编程srebp2驱动的胆固醇合成,在spop突变的前列腺肿瘤中促进雄激素响应性生长和去势抵抗
文章:对TIL细胞治疗无反应的转移性非小细胞肺癌患者的T细胞和新抗原保留受损的时间序列分析
文章:策展的癌细胞图谱提供了单细胞分辨率的肿瘤的全面表征
文章:以人群为基础的胶质瘤分子景观分析在青少年和年轻人揭示胶质瘤形成的见解
文章:肿瘤细胞上的PILRα与T细胞表面蛋白CD99相互作用抑制抗肿瘤免疫

……